Genomics in Oncology Summit - ImmunoOncology Lecture Series Teaser

15 November 2017

Access the full presentations here: http://www.illumina.com/lisbon-lectures Learn how these European cancer researchers are leveraging the power of genomics to gain deeper insights and advance ImmunoOncology (IO) research. Topics range from neoantigen characterization to studying the tumor microenvironment and the influence of the microbiome on immunotherapy in these lectures recorded at the Illumina Genomics in Oncology Summit. • Prof. Mathias Chamaillard, Institut Pasteur de Lille • Prof. Wolf Fridman, University Paris-Descartes Cordeliers • Noel de Miranda, PhD, Leiden University Medical Centre • Dr. Martina Seiffert, DKFZ (German Cancer Research Center) To learn more visit our website: https://www.illumina.com/areas-of-interest/cancer/research/cancer-immunotherapy-research.html For Research Use Only. Not for use in diagnostic procedures.

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.